Exhalation Medical Technology

medical devices

About

EMT was founded in 2011 for the purpose of carrying out research in exhaled breath markers. We seek to make testing for virus rapid, reliable and easy, providing instant results at Point of Care, requiring neither sample handing nor laboratory equipment. Our technology builds on the Inflammacheck®, which is the only device in the market designed to collect Exhaled Breath Condensate, EBC and test for compounds directly therein at Point of Care. We repurpose Inflammacheck® to enable screening for Corona in a similar procedure. To do so, we make an existing sensor platform specific to Corona by immobilizing a receptor to it to which the Corona virus has a very strong affinity. Thus, Corona is expected to bind to the sensor, thereby producing a measurable signal.

Technologies

Render Remote

Keywords

medical equipment manufacturing biotechnology breath analysis monitoring and management electrochemical sensors d2c biosensors biomarkers rapid test under 5 minutes innovative breath sampling point-of-care diagnostics medical equipment and supplies manufacturing exhaled breath condensate covid-19 testing rapid covid-19 test ce marked device point of care testing disease diagnosis groundbreaking clinical trial healthcare technology high specificity and sensitivity disposable test cartridge covid-19 breath test mhra registered clinical trial breath analysis devices healthcare equipment & supplies non-invasive breath test sensors viral detection

Location

42 Newmarket Road, Cambridge, England, United Kingdom, CB5 8EP

Related Companies

Companies in the same industry